Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


Fragment-Based Drug Design

By careful selection and experimental design, fragments can provide very useful starting points for medicinal chemistry-driven programmes, leading to tailor-made, selective molecules with highly favourable physico-chemical and ADMET properties

David Bailey, Susan Boydand Paul England at IOTA Pharmaceuticals Ltd, and Iwan de Esch at IOTA and the Department of Medicinal Chemistry, Vrije Universiteit, Amsterdam (May 2008)

Keywords: The FBDD Approach, Developments in structural biology and high-sensitivity screening, Surface Plasmon RESONANCE (SPR)

    View full article    |    Back to Discovery Technology section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |